MA28601B1 - Acide 4-hydroxy-4-methyl-piperidine-1-carboxylique (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide - Google Patents
Acide 4-hydroxy-4-methyl-piperidine-1-carboxylique (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amideInfo
- Publication number
- MA28601B1 MA28601B1 MA29481A MA29481A MA28601B1 MA 28601 B1 MA28601 B1 MA 28601B1 MA 29481 A MA29481 A MA 29481A MA 29481 A MA29481 A MA 29481A MA 28601 B1 MA28601 B1 MA 28601B1
- Authority
- MA
- Morocco
- Prior art keywords
- benzothiazol
- morpholin
- piperidine
- methoxy
- amide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04102262 | 2004-05-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA28601B1 true MA28601B1 (fr) | 2007-05-02 |
Family
ID=34967309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29481A MA28601B1 (fr) | 2004-05-24 | 2006-11-22 | Acide 4-hydroxy-4-methyl-piperidine-1-carboxylique (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide |
Country Status (39)
Country | Link |
---|---|
US (1) | US7368446B2 (fr) |
EP (1) | EP1753760B1 (fr) |
JP (1) | JP4668265B2 (fr) |
CN (1) | CN1956983B (fr) |
AR (1) | AR048973A1 (fr) |
AT (1) | ATE382619T1 (fr) |
AU (1) | AU2005247567B2 (fr) |
BR (1) | BRPI0511543B1 (fr) |
CA (1) | CA2567703C (fr) |
CR (1) | CR8703A (fr) |
CY (1) | CY1108104T1 (fr) |
DE (1) | DE602005004142T2 (fr) |
DK (1) | DK1753760T3 (fr) |
DO (1) | DOP2005000091A (fr) |
EA (1) | EA011279B1 (fr) |
EC (1) | ECSP067018A (fr) |
ES (1) | ES2297710T3 (fr) |
GT (1) | GT200500124A (fr) |
HK (1) | HK1105199A1 (fr) |
HN (1) | HN2005000238A (fr) |
HR (1) | HRP20080027T3 (fr) |
IL (1) | IL179364A (fr) |
MA (1) | MA28601B1 (fr) |
MX (1) | MXPA06013417A (fr) |
MY (1) | MY140011A (fr) |
NO (1) | NO336939B1 (fr) |
NZ (1) | NZ550763A (fr) |
PA (1) | PA8633901A1 (fr) |
PE (1) | PE20060274A1 (fr) |
PL (1) | PL1753760T3 (fr) |
PT (1) | PT1753760E (fr) |
RS (1) | RS50574B (fr) |
SI (1) | SI1753760T1 (fr) |
SV (1) | SV2006002125A (fr) |
TN (1) | TNSN06371A1 (fr) |
TW (1) | TWI358297B (fr) |
UA (1) | UA87142C2 (fr) |
WO (1) | WO2005116026A1 (fr) |
ZA (1) | ZA200609136B (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE521512C2 (sv) * | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
DK1803444T3 (en) | 2002-12-20 | 2019-02-25 | Niconovum Ab | PROCEDURE FOR PREPARING A NICOTIC PARTICULATE MATERIAL WITH A CRYSTALLINE CELLULOSE (ESPECIALLY MCC) |
WO2007104573A2 (fr) | 2006-03-16 | 2007-09-20 | Niconovum Ab | Composition améliorée de tabac à priser |
BRPI0814672A2 (pt) * | 2007-07-23 | 2014-09-30 | Synosia Therapeutics | Método de tratamento de um paciente, e de distúrbio de estresse pós-traumático, e, métodos para melhorar a resiliência em um paciente e para diagnosticar distúrbio de estresse pós-traumático em um paciente. |
DK2385938T3 (en) | 2009-01-12 | 2015-04-27 | Pfizer Ltd | Sulfonamidderivater |
US8168785B2 (en) | 2009-06-17 | 2012-05-01 | Biotie Therapies, Inc. | Benzothiazole derivatives |
WO2011101861A1 (fr) | 2010-01-29 | 2011-08-25 | Msn Laboratories Limited | Procédé de préparation d'inhibiteurs de la dpp-iv |
US9145407B2 (en) | 2010-07-09 | 2015-09-29 | Pfizer Limited | Sulfonamide compounds |
WO2012060844A1 (fr) * | 2010-11-05 | 2012-05-10 | Biotie Therapies, Inc | Antagonistes a2a en tant que stimulateurs de cognition et de fonction motrice |
WO2013156614A1 (fr) * | 2012-04-20 | 2013-10-24 | Ucb Pharma S.A. | Méthodes de traitement de la maladie de parkinson |
AU2016278846B2 (en) * | 2015-06-19 | 2021-08-05 | Biotie Therapies, Inc. | Controlled-release tozadenant formulations |
WO2018059531A1 (fr) * | 2016-09-30 | 2018-04-05 | 苏州晶云药物科技有限公司 | Forme cristalline d'un médicament antagoniste du récepteur de l'adénosine a 2a , son procédé de préparation et son utilisation |
KR20200043434A (ko) * | 2017-08-21 | 2020-04-27 | 메르크 파텐트 게엠베하 | 아데노신 수용체 길항제로서의 퀴녹살린 유도체 |
TWI791593B (zh) * | 2017-08-21 | 2023-02-11 | 德商馬克專利公司 | 做為腺苷受體拮抗劑之苯并咪唑衍生物 |
WO2019141096A1 (fr) * | 2018-01-19 | 2019-07-25 | 四川科伦博泰生物医药股份有限公司 | Composé d'urée substitué, son procédé de préparation et son utilisation |
EP3897653A1 (fr) | 2018-12-20 | 2021-10-27 | Biotie Therapies, Inc. | Méthodes de traitement du cancer à l'aide de tozadenant |
DE102019110904B4 (de) | 2019-04-26 | 2022-01-20 | Helmholtz-Zentrum Dresden - Rossendorf E. V. | N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH505543A (de) | 1968-11-01 | 1971-04-15 | Ciba Geigy Ag | Schädlingsbekämpfungsmittel |
LU63457A1 (fr) | 1970-07-06 | 1971-11-12 | ||
US4028374A (en) | 1975-11-03 | 1977-06-07 | Morton-Norwich Products, Inc. | Antibacterial thiocyanatobenzothiazoles |
DE2656468A1 (de) | 1976-12-14 | 1978-06-15 | Boehringer Mannheim Gmbh | N-(benzthiazol-2-yl)-oxamidsaeure- derivate und verfahren zu ihrer herstellung |
KR930005004B1 (ko) | 1985-04-15 | 1993-06-11 | 쟈안센 파아마슈우티카 엔. 부이. | 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법 |
FI91859C (fi) | 1987-06-17 | 1994-08-25 | Eisai Co Ltd | Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi |
IL90337A0 (en) | 1988-05-24 | 1989-12-15 | Pfizer | Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents |
WO1990015801A1 (fr) | 1989-06-22 | 1990-12-27 | Pfizer Inc. | Sulfamides substitues et composes apparentes dans le traitement de l'asthme, de l'arthrite et des maladies apparentees |
ES2062248T3 (es) | 1989-11-10 | 1994-12-16 | Agrolinz Agrarchemikalien | Procedimiento para la obtencion de ureas puras, asimetricamente disubstituidas. |
US5376665A (en) | 1992-05-21 | 1994-12-27 | Otsuka Pharmaceutical Factory, Inc. | Phosphonic diester derivatives |
FR2753970B1 (fr) | 1996-10-01 | 1998-10-30 | Synthelabo | Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique |
JPH11130761A (ja) | 1997-10-24 | 1999-05-18 | Otsuka Pharmaceut Co Ltd | ベンゾチアゾール誘導体 |
HUP0102101A3 (en) | 1997-11-10 | 2002-11-28 | Bristol Myers Squibb Co | Protein tyrosine kinase inhibitor benzothiazole derivatives and pharmaceutical compositions containing them |
CA2318969A1 (fr) | 1998-01-23 | 1999-07-29 | Mikhail F. Gordeev | Banques combinatoires d'oxazolidinones, compositions a base de tels composes et procedes de preparation |
JP2002525373A (ja) | 1998-09-30 | 2002-08-13 | ニューロゲン コーポレイション | 2−ピペラジノアルキルアミノベンゾアゾール誘導体:ドーパミン受容体サブタイプ特殊リガンド |
GB9824579D0 (en) | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
UA71587C2 (uk) | 1998-11-10 | 2004-12-15 | Шерінг Акцієнгезелльшафт | Аміди антранілової кислоти та їхнє застосування як лікарських засобів |
IL133680A0 (en) | 1999-09-10 | 2001-04-30 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
WO2001087786A1 (fr) | 2000-05-12 | 2001-11-22 | Corning Incorporated | Procede servant a fabriquer une preforme de fibre optique comportant un revetement protecteur |
CN1234358C (zh) * | 2000-06-21 | 2006-01-04 | 弗·哈夫曼-拉罗切有限公司 | 苯并噻唑衍生物 |
US6727247B2 (en) * | 2001-12-10 | 2004-04-27 | Hoffman-La Roche Inc. | Substituted benzothiazole amide derivatives |
US6713499B2 (en) * | 2001-12-12 | 2004-03-30 | Hoffman-La Roche Inc. | 7-Amino-benzothiazole derivatives |
-
2005
- 2005-05-17 EA EA200602048A patent/EA011279B1/ru not_active IP Right Cessation
- 2005-05-17 BR BRPI0511543-4A patent/BRPI0511543B1/pt not_active IP Right Cessation
- 2005-05-17 SI SI200530160T patent/SI1753760T1/sl unknown
- 2005-05-17 CA CA2567703A patent/CA2567703C/fr active Active
- 2005-05-17 NZ NZ550763A patent/NZ550763A/en not_active IP Right Cessation
- 2005-05-17 PT PT05741185T patent/PT1753760E/pt unknown
- 2005-05-17 WO PCT/EP2005/005329 patent/WO2005116026A1/fr active Application Filing
- 2005-05-17 AT AT05741185T patent/ATE382619T1/de active
- 2005-05-17 UA UAA200613530A patent/UA87142C2/ru unknown
- 2005-05-17 MX MXPA06013417A patent/MXPA06013417A/es active IP Right Grant
- 2005-05-17 RS RSP-2008/0125A patent/RS50574B/sr unknown
- 2005-05-17 JP JP2007513750A patent/JP4668265B2/ja not_active Expired - Fee Related
- 2005-05-17 PL PL05741185T patent/PL1753760T3/pl unknown
- 2005-05-17 CN CN200580016875XA patent/CN1956983B/zh active Active
- 2005-05-17 EP EP05741185A patent/EP1753760B1/fr active Active
- 2005-05-17 ES ES05741185T patent/ES2297710T3/es active Active
- 2005-05-17 DK DK05741185T patent/DK1753760T3/da active
- 2005-05-17 DE DE602005004142T patent/DE602005004142T2/de active Active
- 2005-05-17 AU AU2005247567A patent/AU2005247567B2/en active Active
- 2005-05-18 US US11/132,019 patent/US7368446B2/en active Active
- 2005-05-20 MY MYPI20052309A patent/MY140011A/en unknown
- 2005-05-20 DO DO2005000091A patent/DOP2005000091A/es unknown
- 2005-05-20 TW TW094116495A patent/TWI358297B/zh not_active IP Right Cessation
- 2005-05-23 HN HN2005000238A patent/HN2005000238A/es unknown
- 2005-05-23 PA PA20058633901A patent/PA8633901A1/es unknown
- 2005-05-23 GT GT200500124A patent/GT200500124A/es unknown
- 2005-05-23 PE PE2005000569A patent/PE20060274A1/es active IP Right Grant
- 2005-05-23 AR ARP050102104A patent/AR048973A1/es not_active Application Discontinuation
- 2005-05-24 SV SV2005002125A patent/SV2006002125A/es unknown
-
2006
- 2006-10-24 CR CR8703A patent/CR8703A/es unknown
- 2006-11-02 ZA ZA200609136A patent/ZA200609136B/xx unknown
- 2006-11-14 TN TNP2006000371A patent/TNSN06371A1/fr unknown
- 2006-11-16 IL IL179364A patent/IL179364A/en active IP Right Grant
- 2006-11-21 EC EC2006007018A patent/ECSP067018A/es unknown
- 2006-11-22 MA MA29481A patent/MA28601B1/fr unknown
- 2006-12-12 NO NO20065732A patent/NO336939B1/no not_active IP Right Cessation
-
2007
- 2007-09-27 HK HK07110484.5A patent/HK1105199A1/xx not_active IP Right Cessation
-
2008
- 2008-01-18 HR HR20080027T patent/HRP20080027T3/xx unknown
- 2008-02-28 CY CY20081100232T patent/CY1108104T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA28601B1 (fr) | Acide 4-hydroxy-4-methyl-piperidine-1-carboxylique (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide | |
ATE414693T1 (de) | Neuartige cis-imidazoline | |
DK1871738T3 (da) | N-alkylcarbonylaminosyreester- og N-alkylcarbonylaminolactonforbindelser og deres anvendelse | |
DE602006018478D1 (de) | Ür | |
ATE383329T1 (de) | Biaryloxymethylarenecarbonsäure | |
DE502005008168D1 (de) | Pipette | |
DK1945745T3 (da) | Sur rengøringsmiddelsammensætning | |
DE502005000305D1 (de) | Photobioreaktor | |
DE602005026256D1 (de) | Serien-brückenschaltung | |
AT500549B8 (de) | Klärbecken | |
ATE478853T1 (de) | Thiazolcarbonsäureanilide | |
DE602005006534D1 (de) | Piperidinyl-prostaglandin-e-analoga | |
ITTO20050154U1 (it) | Giocattolo luminoso | |
DE502006009120D1 (de) | Ür | |
FR2877913B1 (fr) | Greement trapeze | |
DE502004008970D1 (de) | Mikrokapseln (XXXII) | |
FI6637U1 (fi) | Kantopeite | |
ATE420094T1 (de) | Substituierte propanphosphinsäureester | |
ATE448990T1 (de) | Autobahnassistent | |
UA13078S (uk) | Флагшток | |
ITBR20050002U1 (it) | Blu ozon ossigeno - ozonotrattamento | |
UA11220S (uk) | Знак інформаційно-попереджувальний | |
UA11944S (uk) | Погони формені | |
SE0402387L (sv) | Avfuktare | |
UA11588S (uk) | Піпетка |